Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Podcasts


Recent Episodes

Experts highlight how updates on the EV-302 and RAMPART studies may influence care across different bladder and kidney cancer populations.
June 25, 2026
ASCO 2026: Practice-Guiding Updates in Bladder and Kidney Cancer
The latest conversation in RadOnc on the Run explores patient and provider considerations for navigating cancer diagnosis, treatment, and recovery.
June 24, 2026
Offering Hope and Support Toward the Cancer Survivorship Journey
Chinmay Jani, MD, discussed work he presented at the 2026 ASCO Meeting and future directions for precision medicine and clinical trials in lung cancer care.
June 22, 2026
Exploring The Future of Artificial Intelligence and Thoracic Oncology
Navigating Personality Disorders in Cancer Care
June 15, 2026
Navigating Personality Disorders in Cancer Care
Experts discuss how updated findings from the TALAPRO-3 and PROTEUS trials may impact the prostate cancer paradigm.
June 11, 2026
ASCO 2026: Translating the Top Prostate Cancer Data Into Clinical Action
Experts discuss abstracts from the 2026 ASCO Annual Meeting that may represent critical advances across multiple myeloma, leukemia, and lymphoma.
June 8, 2026
Unraveling Key Hematologic Oncology Developments at ASCO 2026
Nathan Goodyear, MD, discussed how prescribing exercise may enhance the efficacy of standard oncologic regimens for patients with cancer.
June 1, 2026
Integrating Exercise and Lifestyle Intervention Into Oncologic Therapy
How the Landscape of GI Oncology is Evolving: A 2026 ASCO Preview
May 28, 2026
How the Landscape of GI Oncology is Evolving: A 2026 ASCO Preview
Host Brandon Mancini, MD, MBA, FACRO, discusses stereotactic radiosurgery, proton therapy, and other relevant modalities in the management of brain tumors.
May 27, 2026
Why Do CNS Malignancies Matter in Radiation Oncology?
Mitchell E. Horwitz, MD, discussed how omidubicel and other advances in allogeneic transplantation have impacted different hematologic oncology populations.
May 25, 2026
Navigating the Dynamic Landscape of Stem Cell Transplantation

All series

Recent Episodes

Recent Episodes

Oncology On the Go With ASTCT Talks

Oncology On the Go With ASTCT Talks

ONCOLOGY Decoded

ONCOLOGY Decoded

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

FDA Approval Alert: The Need-to-Know

FDA Approval Alert: The Need-to-Know

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO

Advertisement
Advertisement

Trending on CancerNetwork

1

Where Does LAG-3/PD-1 Inhibition Fit In PD-1–Refractory Hodgkin Lymphoma?

2

VS-7375 Exhibits Activity in KRAS G12D–Mutated Solid Tumors

3

Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial

4

Offering Hope and Support Toward the Cancer Survivorship Journey

5

Cellular Therapy and Antibody-Drug Conjugates Shape Day 1 of ASCO Breakthrough 2026

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us